|Podcasts|July 26, 2022
Breaking Barriers Inside and Outside of Clinical Trials
Author(s)Lisa Henderson, Andy Studna, Senior Editor
Otis Johnson, PhD, Vice President, Product Line Executive; Chief Diversity, Inclusion and Sustainability Officer, at Clario discusses key changes in the industry that have had the greatest impact, Clario’s first ESG report, and how DE&I initiatives will evolve.
Related Content
Trending on Applied Clinical Trials Online
1
Curavit Acquires Lindus Health Clinical Research Organization Assets to Expand US and European Trial Operations
2
When the Slack Runs Out: AI and the CRO Operating Model
3
What Needs to Be True Across Sponsors, Sites, and Regulators for Operation TrialBlazer to Succeed
4
ACT Brief: Trial Failures as Administrative Problems, CRO Consolidation for Global Trial Reach, and FDA Approval of First FOP Treatment
5